# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015612
Filing Date
2024-11-14
Accepted
2024-11-14 07:03:27
Documents
55
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | plx-20240930x10q.htm iXBRL | 10-Q | 1102511
2 | EX-31.1 | plx-20240930xex31d1.htm | EX-31.1 | 12571
3 | EX-31.2 | plx-20240930xex31d2.htm | EX-31.2 | 12740
4 | EX-32.1 | plx-20240930xex32d1.htm | EX-32.1 | 6816
5 | EX-32.2 | plx-20240930xex32d2.htm | EX-32.2 | 6838
6 | GRAPHIC | plx-20240930x10q005.jpg | GRAPHIC | 58451
7 | GRAPHIC | plx-20240930x10q007.jpg | GRAPHIC | 52258
8 | GRAPHIC | plx-20240930x10q008.jpg | GRAPHIC | 33083
| Complete submission text file | 0001558370-24-015612.txt |  | 4864185

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | plx-20240930.xsd | EX-101.SCH | 32008
10 | EX-101.CAL | plx-20240930_cal.xml | EX-101.CAL | 44430
11 | EX-101.DEF | plx-20240930_def.xml | EX-101.DEF | 113028
12 | EX-101.LAB | plx-20240930_lab.xml | EX-101.LAB | 236746
13 | EX-101.PRE | plx-20240930_pre.xml | EX-101.PRE | 191938
58 | EXTRACTED XBRL INSTANCE DOCUMENT | plx-20240930x10q_htm.xml | XML | 647547

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 241457125
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)